Publications by authors named "Martin Sanders"

Claim this Profile
T
Targeting the RXR Pathway for the Prevention of Triple Negative Breast Cancer.
Cassandra L Moyer, Jamal L Hill, Darian Coleman, Amanda Lanier, Yanxia Ma, Martin E Sanders

Cancer Prev Res (Phila)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective retinoid X receptor agonism promotes functional recovery and myelin repair in experimental autoimmune encephalomyelitis.
Gracious D S Kasheke, Basmah A M Hendy, Gabriel G Dorighello, Nonthué A Uccelli, Jean-David M Gothié, Martin E Sanders

Acta Neuropathol Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRX4204 Induces Senescence and Cell Death in HER2-positive Breast Cancer and Synergizes with Anti-HER2 Therapy.
Cassandra L Moyer, Amanda Lanier, Jing Qian, Darian Coleman, Jamal Hill, Martin E Sanders

Clin Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End binding-3 inhibitor activates regenerative program in age-related macular degeneration.
Quinn Lee, Wan Ching Chan, Xinyan Qu, Ying Sun, Hazem Abdelkarim, Martin Sanders

Cell Rep Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.
Cheng-Hsin Wei, Lu Huang, Blair Kreh, Xiuxia Liu, Liliya Tyutyunyk-Massey, Martin E Sanders

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preserving and enhancing mitochondrial function after stroke to protect and repair the neurovascular unit: novel opportunities for nanoparticle-based drug delivery.
Robyn J Novorolsky, Gracious D S Kasheke, Antoine Hakim, Marianna Foldvari, Gabriel G Dorighello, Martin E Sanders

Front Cell Neurosci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engaging the Wisdom of Older Veterans to Enhance VA Healthcare, Research, and Services.
Kathryn A Nearing, Hope M Adams, James Alsphaugh, Serena E Douglas, Thomas R Feller, Susan Martin-Sanders

J Gen Intern Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Retinoid X Receptor Pathway Prevents and Ameliorates Murine Chronic Graft-Versus-Host Disease.
Govindarajan Thangavelu, Michael C Zaiken, Fathima A Mohamed, Ryan Flynn, Jing Du, Martin E Sanders

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1.
Jon H Come, Timothy J Senter, Michael P Clark, John J Court, Zachary Gale-Day, Martin Sanders

J Med Chem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry.
Robert H Edgar, Ahmad Tarhini, Cindy Sander, Martin E Sanders, Justin L Cook

Lasers Surg Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoacoustic detection of circulating melanoma cells in late stage patients.
John A Viator, Marc Hazur, Andrea Sajewski, Ahmad Tarhini, Martin E Sanders

J Innov Opt Health Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AML.
Alexander J Ambinder, Kelly Norsworthy, Daniela Hernandez, Laura Palau, Bogdan Paun, Martin Sanders

Front Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confounding Factors in the Interpretation of Preclinical Studies.
Laura Dill Morton, Martin Sanders, William J Reagan, Torrie A Crabbs, Maralee McVean

Int J Toxicol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease.
Jun Wang, Weina Bi, Wei Zhao, Merina Varghese, Rick J Koch, Martin E Sanders

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How do the top 12 pharmaceutical companies operate safety pharmacology?
Lorna Ewart, David J Gallacher, Gary Gintant, Jean-Michel Guillon, Derek Leishman, Martin Sanders

J Pharmacol Toxicol Methods· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.
Liang Guo, Jian-Yong Qian, Rory Abrams, Hai-Ming Tang, Thomas Weiser, Martin J Sanders

Cell Physiol Biochem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.
Liang Guo, Rory M C Abrams, Joshua E Babiarz, Jennifer D Cohen, Sei Kameoka, Martin J Sanders

Toxicol Sci· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists.
David A Griffith, Diane M Hargrove, Tristan S Maurer, Charles A Blum, Stéphane De Lombaert, Martin J Sanders

Bioorg Med Chem Lett· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
Dinesh Khanna, Philip J Clements, Daniel E Furst, Joseph H Korn, Michael Ellman, Martin E Sanders

Arthritis Rheum· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natalizumab induction and maintenance therapy for Crohn's disease.
William J Sandborn, Jean Frédéric Colombel, Roberts Enns, Brian G Feagan, Stephen B Hanauer, Martin Sanders

N Engl J Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis